Skip to content

Triage Panel for Drugs of Abuse, Plus Tricyclic Antidepressants and Other Triage Drug Tests

by Biosite Incorporated

510(k) K973784

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

4 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK973784 Date3 Dec 1997ClearedStatusActive

Recalls

4 recalls · FDA

    • Completed Z-0418-2018 FDA Class II initiated 14 Nov 2017

    The recalled lots have demonstrated unexpected false positive THC results.

    • Terminated Z-1130-2012 FDA Not yet classified initiated 4 Jan 2012 on shared 510(k) K973784

    Alere San Diego received a rise in customer complaints regarding false positive Barbiturates (BAR) results on the Triage Drugs of Abuse Panel Plus TCA.

    • Terminated Z-0521-2012 FDA Unclassified (pre-2012) initiated 1 Jul 2011

    The recall was initiated because Alere San Diego has confirmed false positive THC results obtained on Triage Drugs of Abuse Plus TCA 25 devices from lots 235991 and 238928.

    • Terminated Z-1088-2009 FDA Unclassified (pre-2012) initiated 6 Nov 2008

    The recall was initiated after the firm's investigations confirmed that, while lot #186625 passed all internal specifications and quality requirements, the incidence of false positive PCP results has exceeded their post market surveillance thresholds for customer complaints in the field. In addition, the firm has been able to reproduce false positive results reported by customers and as a result

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DKZ
Device Class
Class II
Regulation
21 CFR Part 862.3100
Advisory Committee
Clinical Toxicology
FDA Decision
SESE Substantially Equivalent

Other devices from Biosite Incorporated

See all devices from Biosite Incorporated →